Fighting Diagnostic Discrimination and Stigma in Monkeypox
Amid the U.S. monkeypox outbreak, phlebotomists from Labcorp and Quest Diagnostics reportedly turned away blood samples for testing.
Diagnostics
-
Read more: Fighting Diagnostic Discrimination and Stigma in Monkeypox -
Read more: Lessons Learned from the COVID-19 Pandemic: The Future for Diagnostics Lessons Learned from the COVID-19 Pandemic: The Future for Diagnostics
As we look ahead, both current and future pandemics will require tests that give us more granular information about disease.
-
Read more: The Devil is in the Details with Biden’s Free COVID Testing Plan The Devil is in the Details with Biden’s Free COVID Testing Plan
This policy doesn’t seem to encourage frequent and convenient testing now, which is particularly important as we face the current delta surge.
-
Read more: Pandemic Diagnostics: Present and Future Implications of Self-Testing Reimbursement Pandemic Diagnostics: Present and Future Implications of Self-Testing Reimbursement
At-home COVID-19 testing illustrates how even the most well-financed efforts can miss opportunities to ensure equity and expand access.
-
Read more: Call for Abstracts — 2022 Petrie-Flom Center Annual Conference: Diagnosing in the Home Call for Abstracts — 2022 Petrie-Flom Center Annual Conference: Diagnosing in the Home
Contribute to the 2022 Petrie-Flom Center Annual Conference and subsequent book project!
-
Read more: Call for Applications: Research Fellow for Diagnostic Digital Home Health Call for Applications: Research Fellow for Diagnostic Digital Home Health
We’re hiring a full-time post-doctoral fellow to support our newly launched Diagnostic Digital Home Health initiative.
-
Read more: The Petrie-Flom Center Launches New Project: Diagnosing in the Home The Petrie-Flom Center Launches New Project: Diagnosing in the Home
Diagnosing in the Home seeks to examine the ethical, social, and legal challenges of digital home health products.
-
Read more: Laws and Facts of Patent Eligibility and Medical Diagnostics Laws and Facts of Patent Eligibility and Medical Diagnostics
This post is part of our Eighth Annual Health Law Year in P/Review symposium. You can read all of the posts in the series here. Review the conference’s full agenda and register for the event on the Petrie-Flom Center’s website. By Jacob S. Sherkow For this year’s Health Law Year in P/Review, I’ll be talking…
-
Read more: Separating sheep from goats- a European view on the patent eligibility of biomedical diagnostic methods Separating sheep from goats- a European view on the patent eligibility of biomedical diagnostic methods
By Timo Minssen New publication on the patentability of biomedical diagnostics out: Abstract: This brief comment complements Dan Burk’s excellent paper ( Dolly and Alice, J Law and the Biosciences (2015), 1–21, doi:10.1093/jlb/lsv042 ) by providing a very brief summary of the European approach regarding patents on medical diagnostic methods. This serves as the basis for…
-
Read more: Amicus brief in Sequenom v. Ariosa: Why the U.S. Supreme Court should grant the petition for a writ of certiorari Amicus brief in Sequenom v. Ariosa: Why the U.S. Supreme Court should grant the petition for a writ of certiorari
By Timo Minssen I am happy to announce that on April 20th the New York attorney Robert M. Schwartz and I have filed an amicus brief at the US Supreme Court with Berkeley-based Andrew J. Dhuey as Counsel of Record. The brief, which was signed by 10 prominent European and Australian Law Professors as amici curiae, adds a…